top of page

The Full Story


The reality for most small to medium sized companies is that they have to overcome scaling challenges everyday.  I am personally concerned about companies that will not make it through one of their valleys of death (we all know that there are multiple) due to scalability challenges.


For most of my career I have been helping companies who are looking at overcoming scaling challenges.  While working with GE Healthcare we acquired 8 different companies that were small to medium sized companies that needed my help in overcoming scaling challenges to the point that leaders would say that we either needed to overcome the challenges or shutdown the acquired company.  In all cases I was able to work with the leaders and turn the situation around.  

At 5280 Life Sciences, I wanted to build a company that would face into these challenges and by using our ScalingMethod™️ model we could ensure that the latest diagnostics and drugs would make it to market.

Don Davis PhD, MBA (Founder)

Modern Architecture


Our customers are small to midsize life sciences (i.e. pharmaceuticals or diagnostics) companies that are scaling and trying to deal with all of the biggest headaches that threaten their existence (i.e. People not knowing what to do, needless escalations etc.). 


So many times these items take the executive team away from focusing on their strategic goals (i.e. science, raising funds etc.) meaning that the businesses fundamentals (patient, board and investor deliverables) are at stake.

At 5280 Life Sciences, our ScalingMethod™️ model assesses your business’s maturity across the characteristics and capabilities required to become a high-performing organization. We analyze the results and partner with you to design optimized systems and processes making your business operations efficient, compliant and scalable for the future.


At 5280 Life Sciences we offer a suite of products that provide exponential growth supporting small to medium sized companies in the Life Sciences market.  We work with life sciences leaders to help them develop a strategy and roadmap for the future, as well as optimize their operations for growth.

Digital art exhibit
bottom of page